发明名称 |
INHIBITORS OF RECEPTOR FOR ADVANCED GLYCATION-END PRODUCTS (RAGE) FOR USE IN TREATING AND/OR PREVENTING INFLAMMATION- AND/OR DAMAGE-INDUCED CANCER |
摘要 |
The present invention is concerned with measures for tumor therapy. In particular, contemplated is an inhibitor of Receptor for Advanced Glycation-End products (RAGE) for use in treating and/or preventing inflammation- and/or damage-induced cancer. The invention, furthermore, relates to a medicament comprising said inhibitor of RAGE and, preferably, a pharmaceutically acceptable carrier. Further, the invention encompasses a method for identifying a subject in need of treatment with an inhibitor of RAGE, comprising determining in a sample from said subject the amount of RAGE, comparing said amount of RAGE determined in step a) with a reference amount, and identifying a subject in need of treatment with an inhibitor of RAGE. The invention also relates to a device for identifying a subject in need of treatment with an inhibitor of RAGE, as well as a kit adapted to carry out the method of the present invention, said kit comprising instructions for carrying out the aforementioned method. |
申请公布号 |
WO2013153092(A1) |
申请公布日期 |
2013.10.17 |
申请号 |
WO2013EP57454 |
申请日期 |
2013.04.10 |
申请人 |
DEUTSCHES KREBSFORSCHUNGSZENTRUM;RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG;YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREWUNIVERSITY OF JERUSALEM, LTD;HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LTD. |
发明人 |
ANGEL, PETER;PUSTERLA, TOBIAS;HESS, JOCHEN;PIKARSKY, ELI;STEIN, ILAN;KNIGIN, DAVID;BIERHAUS, ANGELIKA |
分类号 |
A61K38/17;A61P35/00 |
主分类号 |
A61K38/17 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|